Marta G. Murreddu is a seasoned professional in clinical research, virology, and project management. She successfully oversaw clinical trials, managed client communications, and ensured adherence to timelines and budgets. From 2021 to 2023, she led Clinical Virology Services at Viroclinics, where she managed teams, handled Phase 1–3 trials, and contributed to the Biosafety Committee. Additionally, she served as Study Director at Xplore, supervising animal biotechnical projects.
Marta holds a PhD in Microbiology from Università Cattolica and a Master’s in Biology from Università degli Studi di Cagliari. Her postdoctoral work, funded by Roche at Georgetown, focused on hepatitis B research, and she managed a BSL3 lab at Virginia Tech. She has published extensively on antiviral effects and vaccine stability and holds certifications in Project Management and Lean Six Sigma. Her strong leadership and strategic skills contribute significantly to global health initiatives.